Last updated 47 days ago

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors

42 patients around the world
Available in Spain, Brazil, United States
Hoffmann-La Roche
1Research sites
42Patients around the world
This study is for people with
Solid tumors
Requirements for the patient
To 17 Years
All Gender
Medical requirements
Sites
Grupo de Apoio Ao Adolescente E A Crianca Com Cancer - GRAACC
Recruiting
Rua Pedro de Toledo, 572 Vila Clementino – São Paulo – SP CEP 04039-001 TEL + 55 11 5080-8400 SAC + 55 11 5080-8569
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy